207 related articles for article (PubMed ID: 17353665)
1. Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy.
Schmitz G; Schmitz-Madry A; Ugocsai P
Curr Opin Lipidol; 2007 Apr; 18(2):164-73. PubMed ID: 17353665
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of cholesterol-lowering therapy.
Schmitz G; Langmann T
Vascul Pharmacol; 2006 Feb; 44(2):75-89. PubMed ID: 16337220
[TBL] [Abstract][Full Text] [Related]
3. Statin and ezetimibe combination therapy in cardiovascular disease.
Dembowski E; Davidson MH
Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of a statine of the most recent generation].
Notarbartolo A; Barbagallo CM
Ital Heart J Suppl; 2001 Mar; 2(3):230-4. PubMed ID: 11307781
[TBL] [Abstract][Full Text] [Related]
5. Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?
Drexel H
Fundam Clin Pharmacol; 2009 Dec; 23(6):687-92. PubMed ID: 19682084
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of statin response.
Mangravite LM; Wilke RA; Zhang J; Krauss RM
Curr Opin Mol Ther; 2008 Dec; 10(6):555-61. PubMed ID: 19051133
[TBL] [Abstract][Full Text] [Related]
7. The genetic determinants of atorvastatin response.
Rodrigues AC; Hirata MH; Hirata RD
Curr Opin Mol Ther; 2007 Dec; 9(6):545-53. PubMed ID: 18041665
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of statin responsiveness.
Kajinami K; Akao H; Polisecki E; Schaefer EJ
Am J Cardiol; 2005 Nov; 96(9A):65K-70K; discussion 34K-35K. PubMed ID: 16291017
[TBL] [Abstract][Full Text] [Related]
9. Lipid management in the geriatric patient.
Nair AP; Darrow B
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
[TBL] [Abstract][Full Text] [Related]
10. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
Hou R; Goldberg AC
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics of lipid-lowering therapies.
Hu M; Tomlinson B
Pharmacogenomics; 2013 Jun; 14(8):981-95. PubMed ID: 23746191
[TBL] [Abstract][Full Text] [Related]
12. Genetic determinants of response to statins.
Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
[TBL] [Abstract][Full Text] [Related]
13. [Statin pharmacokinetics].
Hubácek JA; Adámková V; Zídková K; Ceska R; Zlatohlávek L; Stulc T; Horínek A; Vrablík M
Vnitr Lek; 2008 Jan; 54(1):62-7. PubMed ID: 18390119
[TBL] [Abstract][Full Text] [Related]
14. Combination regimens with statin, niacin, and intestinally active LDL-lowering drugs: alternatives to high-dose statin therapy?
Guyton JR
Curr Opin Lipidol; 2010 Aug; 21(4):372-7. PubMed ID: 20625257
[TBL] [Abstract][Full Text] [Related]
15. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
Jones PH
Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics of statin response.
Mangravite LM; Krauss RM
Curr Opin Lipidol; 2007 Aug; 18(4):409-14. PubMed ID: 17620857
[TBL] [Abstract][Full Text] [Related]
17. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
Goumas GS
Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
Crespo-Leiro MG; Paniagua MJ; Marzoa R; Grille Z; Naya C; Flores X; Rodriguez JA; Mosquera V; Franco R; Castro-Beiras A
Transplant Proc; 2008 Nov; 40(9):3060-2. PubMed ID: 19010194
[TBL] [Abstract][Full Text] [Related]
19. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
20. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
Vaverková H
Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
